StemCells, Inc. – Stewart Craig, Ph.D. 960 North California Avenue Palo Alto, CA 94303 Dear Stewart, (March 11th, 2010)
On behalf of StemCells, Inc., I am pleased to offer you the position of Senior Vice President, Development and Operations, on the following terms and conditions:
StemCells, Inc. – Asset Purchase Agreement (March 16th, 2009)
This Asset Purchase Agreement (this Agreement), is entered into and effective as of March 1, 2009 (the Effective Date), by and between StemCells, Inc. a Delaware corporation whose address is at 3155 Porter Drive, Palo Alto, CA 94304 (the Purchaser), and Stem Cell Sciences plc (Registered Number 05455929), a public limited company registered in England and Wales having its Registered Office at Meditrina Building 260, Babraham Research Campus, Cambridge CB22 3A, United Kingdom (the Seller).
Separation Agreement and Release (May 18th, 2005)
This Separation Agreement and Release (Agreement) is entered into as of this 17th day of May, 2005 (hereinafter Execution Date) by and between Stewart Craig (hereinafter Employee), and Xcyte Therapies, Inc., its affiliates, successors and assigns (hereinafter the Company). Employee and the Company are sometimes collectively referred to as the Parties.